IMHL participant spearheads TB vaccine trial in Mumbai

News

Published: 6Sep2019

Dr. Daksha Shah (IMHL’20) is leading a new TB vaccine trial in Mumbai, where an estimated 40 to 50 percent of the population carries a latent TB infection. The pilot project focuses on providing treatment to close contacts of TB patients.

Read more

Editor feedback

For more information or if you would like to report an error, please web.desautels [at] mcgill.ca (subject: Website%20News%20Comments) (contact us).

Coronavirus (COVID-19)

Updated: 2020/10/01

For the latest information on McGill University's response to COVID-19, please visit the Coronavirus Information website.

For Desautels specific updates please visit our COVID-19 FAQ page.

Back to top